Tarsa Therapeutics Develops An Oral Formulation Of Calcitonin For The Treatment And Prevention Of Postmenopausal Osteoporosis And Bone Diseases
No conferences found for this company.
| Company Name | Tarsa Therapeutics Inc |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
Enter your address and we will specify the offer for your area.